Key2Brain is a Swedish biotechnology company committed to developing a novel and efficacious brain targeting platform technology.

With unique molecules and preclinical expertise, Key2Brain provides solutions for enhanced brain uptake of biologics and diagnostics. Key2Brain is a partner for preclinical development of therapeutics treating the central nervous system (CNS).

Our goal is to improve treatment and diagnostic options for diseases of the CNS.